“Brush Sign” on Susceptibility-Weighted MR Imaging Indicates the Severity of Moyamoya Disease

References

1. 1.↵
   1. Suzuki J,
   2. Takaku A.

   . Cerebrovascular “Moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969; 20: 288–99

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Suzuki J,
   2. Kodama N.

   . Moyamoya disease—a review. Stroke 1983; 14: 104–09

   Abstract/FREE Full Text
3. 3.↵
   1. Kuroda S,
   2. Houkin K.

   . Moyamoya disease: current concepts and future perspectives. Lancet Neurol 2008; 7: 1056–66

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Lee M,
   2. Zaharchuk G,
   3. Guzman R,
   4. et al

   . Quantitative hemodynamic studies in Moyamoya disease: a review. Neurosurg Focus 2009; 26: E5

   PubMed
5. 5.↵
   1. Tanaka Y,
   2. Nariai T,
   3. Nagaoka T,
   4. et al

   . Quantitative evaluation of cerebral hemodynamics in patients with Moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging—comparison with positron emission tomography. J Cereb Blood Flow Metab 2006; 26: 291–300

   CrossRefPubMed
6. 6.↵
   1. Honda M,
   2. Ezaki Y,
   3. Kitagawa N,
   4. et al

   . Quantification of the regional cerebral blood flow and vascular reserve in Moyamoya disease using split-dose iodoamphetamine I 123 single-photon emission computed tomography. Surg Neurol 2006; 66: 155–59

   CrossRefPubMed
7. 7.↵
   1. Imaizumi M,
   2. Kitagawa K,
   3. Hashikawa K,
   4. et al

   . Detection of misery perfusion with split-dose 123I-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases. Stroke 2002; 33: 2217–23

   Abstract/FREE Full Text
8. 8.↵
   1. Tong KA,
   2. Ashwal S,
   3. Obenaus A,
   4. et al

   . Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol 2008; 29: 9–17

   Abstract/FREE Full Text
9. 9.↵
   1. Fukui M.

   . Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘Moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997; 99 Suppl 2: S238–40

   PubMedWeb of Science
10. 10.↵
    1. Sehgal V,
    2. Delproposto Z,
    3. Haacke EM,
    4. et al

    . Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005; 22: 439–50

    CrossRefPubMed
11. 11.↵
    1. Wycliffe ND,
    2. Choe J,
    3. Holshouser B,
    4. et al

    . Reliability in detection of hemorrhage in acute stroke by a new three-dimensional gradient recalled echo susceptibility-weighted imaging technique compared to computed tomography: a retrospective study. J Magn Reson Imaging 2004; 20: 372–77

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Lee BC,
    2. Vo KD,
    3. Kido DK,
    4. et al

    . MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. AJNR Am J Neuroradiol 1999; 20: 1239–42

    Abstract/FREE Full Text
13. 13.↵
    1. Reichenbach JR,
    2. Jonetz-Mentzel L,
    3. Fitzek C,
    4. et al

    . High-resolution blood oxygen-level dependent MR venography (HRBV): a new technique. Neuroradiology 2001; 43: 364–69

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Essig M,
    2. Reichenbach JR,
    3. Schad LR,
    4. et al

    . High-resolution MR venography of cerebral arteriovenous malformations. Magn Reson Imaging 1999; 17: 1417–25

    CrossRefPubMed
15. 15.↵
    1. Noguchi K,
    2. Kuwayama N,
    3. Kubo M,
    4. et al

    . Intracranial dural arteriovenous fistula with retrograde cortical venous drainage: use of susceptibility-weighted imaging in combination with dynamic susceptibility contrast imaging. AJNR Am J Neuroradiol 2010; 31: 1903–10

    Abstract/FREE Full Text
16. 16.↵
    1. Bartzokis G,
    2. Tishler TA.

    . MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntington's disease. Cell Mol Biol (Noisy-le-grand) 2000; 46: 821–33

    PubMedWeb of Science
17. 17.↵
    1. Bartzokis G,
    2. Cummings JL,
    3. Markham CH,
    4. et al

    . MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 1999; 17: 213–22

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Hecht MJ,
    2. Fellner C,
    3. Schmid A,
    4. et al

    . Cortical T2 signal shortening in amyotrophic lateral sclerosis is not due to iron deposits. Neuroradiology 2005; 47: 805–08

    CrossRefPubMed
19. 19.↵
    1. Sehgal V,
    2. Delproposto Z,
    3. Haddar D,
    4. et al

    . Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 2006; 24: 41–51

    CrossRefPubMed
20. 20.↵
    1. Greenberg SM,
    2. O'Donnell HC,
    3. Schaefer PW,
    4. et al

    . MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology 1999; 53: 1135–38

    Abstract/FREE Full Text
21. 21.↵
    1. Tamura H,
    2. Hatazawa J,
    3. Toyoshima H,
    4. et al

    . Detection of deoxygenation-related signal change in acute ischemic stroke patients by T2*-weighted magnetic resonance imaging. Stroke 2002; 33: 967–71

    Abstract/FREE Full Text
22. 22.↵
    1. Kobayashi E,
    2. Saeki N,
    3. Oishi H,
    4. et al

    . Long-term natural history of hemorrhagic Moyamoya disease in 42 patients. J Neurosurg 2000; 93: 976–80

    CrossRefPubMed
23. 23.↵
    1. Kawaguchi S,
    2. Okuno S,
    3. Sakaki T.

    . Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of Moyamoya disease. J Neurosurg 2000; 93: 397–401

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Kuroda S,
    2. Houkin K,
    3. Ishikawa T,
    4. et al

    . Novel bypass surgery for Moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome. Neurosurgery 2010; 66: 1093–101

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Kuroda S,
    2. Houkin K,
    3. Kamiyama H,
    4. et al

    . Effects of surgical revascularization on peripheral artery aneurysms in Moyamoya disease: report of three cases. Neurosurgery 2001; 49: 463–67

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Nariai T,
    2. Matsushima Y,
    3. Imae S,
    4. et al

    . Severe haemodynamic stress in selected subtypes of patients with Moyamoya disease: a positron emission tomography study. J Neurol Neurosurg Psychiatry 2005; 76: 663–69

    Abstract/FREE Full Text
27. 27.↵
    1. Piao R,
    2. Oku N,
    3. Kitagawa K,
    4. et al

    . Cerebral hemodynamics and metabolism in adult Moyamoya disease: comparison of angiographic collateral circulation. Ann Nucl Med 2004; 18: 115–21

    PubMed
28. 28.↵
    1. Kuwabara Y,
    2. Ichiya Y,
    3. Otsuka M,
    4. et al

    . Cerebral hemodynamic change in the child and the adult with Moyamoya disease. Stroke 1990; 21: 272–77

    Abstract/FREE Full Text
29. 29.↵
    1. Kuwabara Y,
    2. Ichiya Y,
    3. Sasaki M,
    4. et al

    . Cerebral hemodynamics and metabolism in Moyamoya disease—a positron emission tomography study. Clin Neurol Neurosurg 1997; 99 Suppl 2: S74–78

    PubMed
30. 30.↵
    1. Kikuta K,
    2. Takagi Y,
    3. Nozaki K,
    4. et al

    . Histological analysis of microbleed after surgical resection in a patient with Moyamoya disease. Neurol Med Chir (Tokyo) 2007; 47: 564–67

    CrossRefPubMed
31. 31.↵
    1. Mori N,
    2. Miki Y,
    3. Kikuta K,
    4. et al

    . Microbleeds in Moyamoya disease: susceptibility-weighted imaging versus T2*-weighted imaging at 3 Tesla. Invest Radiol 2008; 43: 574–79

    CrossRefPubMed
32. 32.↵
    1. Kikuta K,
    2. Takagi Y,
    3. Nozaki K,
    4. et al

    . Asymptomatic microbleeds in Moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg 2005; 102: 470–75

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Ishikawa T,
    2. Kuroda S,
    3. Nakayama N,
    4. et al

    . Prevalence of asymptomatic microbleeds in patients with Moyamoya disease. Neurol Med Chir (Tokyo) 2005; 45: 495–500

    CrossRefPubMed
34. 34.↵
    1. Fujii K,
    2. Ikezaki K,
    3. Irikura K,
    4. et al

    . The efficacy of bypass surgery for the patients with hemorrhagic Moyamoya disease. Clin Neurol Neurosurg 1997; 99 Suppl 2: S194–95

    PubMed